Subscribe
Sign In
Tag: CBT > Aurora Cannabis Canada
International
Aurora Cannabis Enters $27 Million Supply Agreement With SNDL
The agreement for SNDL to supply Aurora with premium cannabis flower complements the companies’ existing relationship.
February 7, 2025
Finance
Aurora Cannabis Reports Net Revenue of $88 Million for Fiscal 2025 3Q Results
The company’s net revenue is up 37% year-over-year, including a record net revenue of 68 million dollars in global medical cannabis.
February 5, 2025
International
Empowering the Next Generation: Aurora Cannabis Announces German Internship Program
The cannabis company launched the program at its manufacturing facility in Leuna, Germany, to cultivate future leaders in the medical cannabis industry.
January 10, 2025
Finance
Aurora Cannabis Announces Fiscal 2025 Second Quarter Results
The company’s international revenue increased 93% to $35 million, exceeding Canadian medical revenue for the first time.
November 7, 2024
Industry Headlines
Aurora Introduces Innovative Cannabis Oil Range in Australia
The Canadian cannabis company and MedReleaf Australia launched the oil products to offer enhanced patient car options.
October 16, 2024
Industry Headlines
Aurora Cannabis Collaborates on Genome BC-Funded Project Addressing Distinct Aromas
A research grant for a project designed to validate breeding genetics connected with fruity aroma will enhance Aurora’s breeding program.
October 2, 2024
Executive Leadership Team
Aurora Cannabis CEO Takes on Executive Chairman Role
Miguel Martin is expanding his duties as part of a board leadership transition with outgoing Chairman Ron Funk appointed as lead independent director.
September 20, 2024
Cannabis Industry Research
Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Cultivation
The research breakthroughs are poised to transform cannabis cultivation in high-latitude regions, opening new doors for advanced breeding strategies.
September 17, 2024
Cannabis Business Financial Report
Aurora Cannabis Announces Fiscal 2025 First Quarter Results and Delivers Positive Free Cash Flow
The Canadian company notes positive free cash flow of $6.5 million, record net revenue of $47.2 million in global medical cannabis and an end to the fiscal quarter debt-free with a cash position of approximately $182 million.
August 7, 2024
Industry Headlines
Aurora Receives Expanded Cultivation, Unique Research Licenses for German Facility
The company’s long-standing investment in the region continues with enhanced local production and domestic cultivar research.
July 25, 2024
Industry Headlines
Aurora Marks 1st Medical Cannabis Shipment to New Zealand Market
The Canadian cannabis company launched its premium products aimed at redefining patient care.
May 8, 2024
International
Aurora Cannabis Achieves Australia's TGA GMP Certification
The Canadian-based company’s achievement solidifies its leadership in the Australian market and sets a global standard for quality and compliance
March 20, 2024
Page 1 of 5
Next Page